MediWound Ltd. | Ownership

Companies that own MediWound Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Wellington Management Co. LLP
3,784,794
13.93%
-1,889
0%
06/30/2018
Migdal Insurance Co. Ltd. (Investment Portfolio)
2,098,277
7.72%
21,559
0.28%
06/30/2018
Migdal Makefet Pension & Provident Funds Ltd.
1,992,422
7.33%
523,421
0.7%
12/31/2017
Yelin Lapidot Mutual Fund Management Ltd.
1,432,381
5.27%
180,000
0.71%
12/31/2017
Harel-Pia Mutual Funds Ltd.
754,434
2.78%
0
0.2%
06/30/2018
Meitav Ds Mutual Funds Ltd.
505,343
1.86%
14,050
0.11%
06/30/2018
Broadfin Capital LLC
477,100
1.76%
-22,900
0.41%
06/30/2018
U-Bank Mutual Funds Ltd.
439,800
1.62%
-109,300
2.87%
06/28/2018
Baker Bros. Advisors LP
226,000
0.83%
0
0.01%
06/30/2018
USAA Asset Management Co.
209,442
0.77%
0
0%
06/30/2018

About MediWound

View Profile
Address
42 Hayarkon Street
Yavne HM 8122745
Israel
Employees -
Website http://www.mediwound.com
Updated 07/08/2019
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialize novel products to address unmet needs in the fields of severe burn; chronic and other hard-to-heal wounds; and connective tissue disorders. Its medicinal product, NexoBrid, is used to remove eschar in adults patients with deep partial- and full-thickness thermal burns. The company was founded by Lior Rosenberg and Marian Gorecki on January 27, 2000 and is headquartered in Yavne, Israel.